DCP-LA
DCP-LA (FR236924), a linoleic acid derivative, selectively and directly activates PKCε. DCP-LA activates Ca (2+) /calmodulin-dependent protein kinase II (CaMKII) and inhibits protein phosphatase-1 (PP-1) to stimulate AMPA receptor exocytosis. DCP-LA inhibits activation of caspase-3/-9 and protects neurons at least in part from oxidative stress-induced apoptosis[1][2][3].
Product Specifications
CAS Number
28399-31-7
Product Name Alternative
FR236924
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; CaMK; Phosphatase; PKC
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; Metabolic Enzyme/Protease; Neuronal Signaling; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/DCP-LA.html
Purity
98.00
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)CCCCCCCC1C(CC2C(CCCCC)C2)C1
Molecular Formula
C20H36O2
Molecular Weight
308.50
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CaMK II; PKCε
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
IPG -2 AM - yellow -green fluorescent potassium indicator
IgA Secretory Component (ECM1/792), CF594 conjugate, 0.1mg/mL
